Item 8.01 Other Events
As previously reported, on
On
CytoDyn further announced that intends to continue studying leronlimab in other
HIV-related indications, which
2
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -98.31% | -.--% | -98.31% |
2023 | Regnum Corp. Announces Resignation of Anne Kirby as Chief Executive Officer | CI |
2023 | Regnum Corp. Announces Resignation of Anne Kirby as Sole Member of Board of Directors | CI |
Item 8.01 Other Events
As previously reported, on
On
CytoDyn further announced that intends to continue studying leronlimab in other
HIV-related indications, which
2
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
-98.31% | 2.3K | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.01% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
-1.62% | 11.98B |